Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...

Myasthenia gravis is an autoimmune disorder in which antibodies disrupt the communication between nerves and muscles, ...

Sanofi said on Thursday that it would acquire Vigil Neuroscience, a clinical-stage biotech company, for $8 per share in cash, ...

Andretti and Marcus Ericsson drive Allegra into Indianapolis 500 as the 2022 winner and his team join the allergy brand for ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

Aventis Energy (CSE: AVE; OTC: VBAMF) provided a comprehensive summary of exploration insights and historical data gathered ...

Eosinophilic esophagitis (EoE) is a multifaceted disease marked by diverse clinical features, including variations in age of ...

France's finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the ...

(Reuters) -French drugmaker Sanofi said on Wednesday it plans to invest at least $20 billion in the United States through ...

The French drugmaker, one of the world's largest vaccine makers and a leader in anti-inflammatory drugs, said on Wednesday it ...

Sanofi SAN-1.57%decrease; red down pointing triangle plans to spend about $1.05 billion building a new insulin manufacturing base in China, the French company’s largest single investment in the ...